Protein-tyrosine phosphatase inhibitors and uses thereof

Details Protein-tyrosine phosphatase inhibitors and uses thereof Protein-tyrosine phosphatase inhibitors and uses thereof

2007-01-30

2007-01-30

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S331000, C514S362000, C514S365000, C514S374000, C514S381000, C514S383000, C546S189000, C548S136000, C548S143000, C548S202000, C548S206000, C548S215000, C548S240000, C548S262200, C548S335500

Reexamination Certificate

active

10771926

ABSTRACT:
The present invention is directed to compounds of formula (I),or a pharmaceutically suitable salt or prodrug thereof, which are useful for the selective inhibition of protein tyrosine phosphatase-1B (PTP1B), and are useful for the treatment of disorders caused by overexpressed or altered protein tyrosine phosphatase 1B.

REFERENCES:
patent: 0117516 (2001-03-01), None
patent: 0119830 (2001-03-01), None
patent: 0119831 (2001-03-01), None
Barret et al., Solid-phase Synthesis of Isoxazoles Using Vinyl Ethers as Chameleon Catches, Organic Latter, vol. 3, No. 20, pp. 3165-3168.
Ahmad, F., et al., “Osmotic Loading of Neutralizing Antibodies Demonstrates a Role for Protein-tyrosine Phosphatase 1B in Negative Regulation of the Insulin Action Pathway (*)”,Jour. Biol. Chem, 270(35):20503-20508 (1995.
Bryant, N. J., et al., “Regulated Transport of the Glucose Transporter Glut4”,Nature Reviews. 3:267-277 (2002).
Cheng, A., et al., “Coordinated action of protein tyrosine phosphatases in insulin signal transduction”,Eur. J. Biochem., 269:1050-1059 (2002).
Dunstan, D. W., et al., “The Rising Prevalence of Diabetes and Impaired Glucose Tolerance: The Australian Diabetes, Obesity and Lifestyle Study”,Diabetes Care, 25(5)829-834 (2002).
Elchebly, M., et al., “Increased Insulin Sensitivity and Obesity Resistance in Mice Lacking the portein Tyrosine Phosphatase-1B Gene”,Science, 283:1544-1548 (1999).
Flint, A. J., et al., “Multi-site phosphorylation of the protein tyrosine phosphatase, PTP1B: identification of cell cycle regulated and phorbol ester stimulated sites of phosphorylation”,The EMBO Jour., 12(5)1937-1946 (1993).
Goldstein, B. J., et al., “Tyrosine Dephosphorylation and Deactivation of Insulin Receptor Substrate-1 by Protein-tyrosine Phosphatase 1B”,Jour. Biol. Chem., 275(6):4283-4289 (2000).
Groop, L. & Orho-Melander, M., “The dysmetabolic syndrome”,Jour. of Internal Med., 250:105-120 (2001).
Klaman, L. D., et al., “Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice”,Molecular and Cellular Biol., 20(15):5479-5489 (2000).
Mauro, L. J., et al., “Identification of a Hormonally Regulated Protein Tyrosine Phosphatase Associated with Bone and Testicular Differentiation”,The Journ. of Biol. Chem., 269:30659-30667 (1994).
Noguchi, T., et al., “Role of SH-PTP2, a Protein-Tyrosine Phosphatase with Src Homology 2 Domains, in Insulin-Stimulated Ras Activation”,Mol. and Cell. Biol., 14(10):6674-6682 (1994).
Ostman, A. & Böhmer, F-D., “Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases”,Trends Cell Biol., 11:258-266 (2001).
Saltiel, A. R., & Pessin, J. E., “Insulin signaling pathways in time and space”,Treands in Cell Biol., 12(2):65-71 (2001).
Seely, L. B., et al., “Protein Tyrosine Phosphatase 1B Interacts With the Activated Insulin Receptor”,diabetes, 4(10):1379-1385 (1996).
Wang, Q., et al., “Mechanism of Inhibition of Protein-Tyrosine Phosphatases by Disodium Aurothiomalate”,Biochem. Pharma., 54:703-711 (1997).
Wiener, J. R., et al., “Overexpression of the Protein Tyrosine Phosphatase PTP1B in Human Breast Cancer: Association With p185c-erbB-2Protein Expression”,Journ of the Nat'l Cancer Insti., 86(5):372-378 (1994).
Zabolotny, J. M., et al., “PTO1B Regulates Leptin Signal Transduction in ViVo”,Developmental Cell, 2:489-495 (2002).
Zinker, B. A., et al., “PTP1B antisense oligonucleotide lowers PTO1B protein, normalizes blood glucose, and improves insulin sensitivity indiabetic mice”,Proc. Natl. Acad. Sci. USA, 99(17):11357-11362 (2002).

Affiliated with

Also associated with

Rating

Protein-tyrosine phosphatase inhibitors and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protein-tyrosine phosphatase inhibitors and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein-tyrosine phosphatase inhibitors and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3725773